Last reviewed · How we verify
RAD 001 in combination with Caelyx — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
RAD 001 in combination with Caelyx (RAD 001 in combination with Caelyx) — Southern Europe New Drug Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| RAD 001 in combination with Caelyx TARGET | RAD 001 in combination with Caelyx | Southern Europe New Drug Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- RAD 001 in combination with Caelyx CI watch — RSS
- RAD 001 in combination with Caelyx CI watch — Atom
- RAD 001 in combination with Caelyx CI watch — JSON
- RAD 001 in combination with Caelyx alone — RSS
Cite this brief
Drug Landscape (2026). RAD 001 in combination with Caelyx — Competitive Intelligence Brief. https://druglandscape.com/ci/rad-001-in-combination-with-caelyx. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab